R
Rebecca L. Stepien
Researcher at University of Wisconsin-Madison
Publications - 67
Citations - 4104
Rebecca L. Stepien is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Heart failure & Blood pressure. The author has an hindex of 30, co-authored 65 publications receiving 3288 citations.
Papers
More filters
Journal ArticleDOI
Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats
Scott A. Brown,Clarke E. Atkins,Rodney S. Bagley,Anthony P. Carr,Larry D Cowgill,Michael G. Davidson,Beate Egner,Jonathan Elliott,Rosemary A. Henik,Mary Anna Labato,Meryl P. Littman,David J. Polzin,Linda A. Ross,Patti S. Snyder,Rebecca L. Stepien +14 more
TL;DR: The Consensus Statement is intended to be a guide for veterinarians, but it is not a statement of standard of care or a substitute for clinical judgment.
Journal ArticleDOI
Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart Disease
Clarke E. Atkins,John D. Bonagura,Steven M. Ettinger,Philip R. Fox,Sonya G. Gordon,Jens Häggström,Robert L. Hamlin,Bruce W. Keene,Virginia Luis-Fuentes,Rebecca L. Stepien +9 more
Journal ArticleDOI
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.
Bruce W. Keene,Clarke E. Atkins,John D. Bonagura,John D. Bonagura,Philip R. Fox,Jens Häggström,Virginia Luis Fuentes,Mark A. Oyama,John E. Rush,Rebecca L. Stepien,Masami Uechi +10 more
TL;DR: In this paper, the authors present guidelines for the diagnosis and treatment of myxomatous mitral valve disease (MMVD), also known as endocardiosis and degenerative or chronic valvular heart disease in dogs.
Journal ArticleDOI
ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats
Mark J. Acierno,Scott Brown,Amanda E. Coleman,Rosanne E. Jepson,Mark G. Papich,Rebecca L. Stepien,Harriet M. Syme +6 more
TL;DR: An update to the 2007 American College of Veterinary Internal Medicine consensus statement on the identification, evaluation, and management of systemic hypertension in dogs and cats was presented at the 2017 ACVIM Forum in National Harbor, MD.
Journal ArticleDOI
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study - A Randomized Clinical Trial
Adrian Boswood,Jens Häggström,Sonya G. Gordon,Gerhard Wess,Rebecca L. Stepien,Mark A. Oyama,Bruce W. Keene,John D. Bonagura,Kristin A. MacDonald,M. Patteson,Sarah Smith,Philip R. Fox,Karen Sanderson,Richard Woolley,Viktor Szatmári,Pierre Menaut,Whitney M. Church,M. L. O'Sullivan,J-P Jaudon,J-G Kresken,John E. Rush,Kirstie A. Barrett,Steven L. Rosenthal,Ashley B. Saunders,Ingrid Ljungvall,M. Deinert,Eric Bomassi,Amara H. Estrada,M. J. Fernández del Palacio,N.S. Moïse,Jonathan A. Abbott,Yoko Fujii,Alan W. Spier,Michael W. Luethy,Roberto A. Santilli,Masami Uechi,Anna Tidholm,P. Watson +37 more
TL;DR: Administration of pimobendan to dogs with MMVD and echocardiographic and radiographic evidence of cardiomegaly results in prolongation of preclinical period and is safe and well tolerated.